Mednet Logo
HomeMedical OncologyQuestion

What scenario would flipped dosing versus standard dosing of ipilimumab + nivolumab be beneficial in metastatic melanoma?

1
1 Answers
Mednet Member
Mednet Member
Medical Oncology · University Of Wisconsin Carbone Cancer Center

Based on the CheckMate 511 study, the flipped dosing (ipi1/nivo3) demonstrated reduced high-grade (grade 3+) toxicities compared to the standard dose (ipi3/nivo1) [33.9% vs 48.3%, respectively]. In advanced melanoma patients who would benefit from combination ipi/nivo, I preferentially use the flipp...

Register or Sign In to see full answer

What scenario would flipped dosing versus standard dosing of ipilimumab + nivolumab be beneficial in metastatic melanoma? | Mednet